These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 14635365

  • 21. Vasodilators and inotropic agents in the treatment of congestive heart failure.
    Francis GS.
    Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651
    [Abstract] [Full Text] [Related]

  • 22. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN.
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [Abstract] [Full Text] [Related]

  • 23. Review of current and investigational pharmacologic agents for acute heart failure syndromes.
    Shin DD, Brandimarte F, De Luca L, Sabbah HN, Fonarow GC, Filippatos G, Komajda M, Gheorghiade M.
    Am J Cardiol; 2007 Jan 22; 99(2A):4A-23A. PubMed ID: 17239703
    [Abstract] [Full Text] [Related]

  • 24. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug 22; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

  • 25. Management of acute decompensated heart failure: renal implications.
    Virani SA.
    Blood Purif; 2008 Aug 22; 26(1):18-22. PubMed ID: 18182790
    [Abstract] [Full Text] [Related]

  • 26. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM, O'Connor CM.
    Am Heart J; 2001 Sep 22; 142(3):393-401. PubMed ID: 11526351
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
    Kirk JD, Parissis JT, Filippatos G.
    Heart Fail Clin; 2009 Jan 22; 5(1):43-54, vi. PubMed ID: 19026385
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS, Sandell EP.
    Ital Heart J; 2003 May 22; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [Abstract] [Full Text] [Related]

  • 34. Optimizing outcomes in the patient with acute decompensated heart failure.
    Mehra MR.
    Am Heart J; 2006 Mar 22; 151(3):571-9. PubMed ID: 16504617
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J, ADHERE Scientific Advisory Committee and Investigators, ADHERE Study Group.
    J Am Coll Cardiol; 2005 Jul 05; 46(1):57-64. PubMed ID: 15992636
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Therapy of heart failure. I. Definition, pathophysiology, therapy of acute heart failure].
    Schwinger RH, Erdmann E.
    Fortschr Med; 1997 Jun 10; 115(16):30-4. PubMed ID: 9280746
    [Abstract] [Full Text] [Related]

  • 40. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C.
    Pharmacol Ther; 2007 May 10; 114(2):184-97. PubMed ID: 17363065
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.